See more : The KCP Limited (KCP.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Silo Wellness Inc. (SILFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Silo Wellness Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Hawaiian Electric Industries, Inc. (HE) Income Statement Analysis – Financial Results
- Protalix BioTherapeutics, Inc. (PLX.TA) Income Statement Analysis – Financial Results
- Tiangong International Company Limited (0826.HK) Income Statement Analysis – Financial Results
- Aura Energy Limited (AUEEF) Income Statement Analysis – Financial Results
- SOFTRAK VENTURE INVESTMENT LTD (SOFTRAKV.BO) Income Statement Analysis – Financial Results
Silo Wellness Inc. (SILFF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.silowellness.com
About Silo Wellness Inc.
Silo Wellness Inc., a psychedelics and wellness company, develops psychedelic medicine to reduce trauma. It develops and sells psilocybin-free functional mushroom tinctures; and the formulation of a psilocybin nasal spray in Jamaica. It also offers a portfolio of functional mushroom products: Jamaican and Oregon psychedelic wellness retreats, as well as cultivates psychedelic mushrooms and truffles in Jamaica; and develops bricks and mortar smart shop in Jamaica. The company was formerly known as Yukoterre Resources Inc. and changed its name to Silo Wellness Inc. February 26, 2021. Silo Wellness Inc. is headquartered in Toronto, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 335.81K | 120.12K | 6.22K | 0.00 |
| Cost of Revenue | 212.85K | 388.61K | 48.51K | 0.00 |
| Gross Profit | 122.96K | -268.49K | -42.29K | 0.00 |
| Gross Profit Ratio | 36.62% | -223.52% | -679.86% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.49M | 3.15M | 958.00K | 1.43M |
| Selling & Marketing | 3.64M | 1.52M | 62.20K | 158.63K |
| SG&A | 5.13M | 4.67M | 1.02M | 1.59M |
| Other Expenses | 0.00 | 54.52K | 327.12K | 0.00 |
| Operating Expenses | 122.96K | 4.72M | 1.35M | 1.63M |
| Cost & Expenses | 6.14M | 5.11M | 1.40M | 1.63M |
| Interest Income | 0.00 | 68.73K | 1.85K | 2.69K |
| Interest Expense | 12.41K | 68.73K | 1.85K | 0.00 |
| Depreciation & Amortization | -792.75K | 54.52K | 327.12K | 44.85K |
| EBITDA | -5.80M | -6.09M | -1.06M | -1.59M |
| EBITDA Ratio | -1,727.16% | -4,108.22% | -17,081.66% | 0.00% |
| Operating Income | -5.01M | -4.99M | -1.39M | -1.63M |
| Operating Income Ratio | -1,491.09% | -4,153.60% | -22,340.77% | 0.00% |
| Total Other Income/Expenses | -805.16K | -1.22M | 3.93K | -3.45K |
| Income Before Tax | -5.81M | -6.21M | -1.39M | -1.63M |
| Income Before Tax Ratio | -1,730.85% | -5,168.90% | -22,277.56% | 0.00% |
| Income Tax Expense | 0.00 | -1.15M | 5.78K | 0.00 |
| Net Income | -5.81M | -6.21M | -1.39M | -1.63M |
| Net Income Ratio | -1,730.85% | -5,168.90% | -22,277.56% | 0.00% |
| EPS | -1.74 | -4.00 | -0.88 | -7.34 |
| EPS Diluted | -1.74 | -4.00 | -0.88 | -7.34 |
| Weighted Avg Shares Out | 3.33M | 1.55M | 1.56M | 222.27K |
| Weighted Avg Shares Out (Dil) | 3.33M | 1.55M | 1.56M | 222.27K |
Silo Wellness Announces Extension of Kaya/NUGL LOI; Annual Filings Delay
Silo Wellness Announces LOI to Acquire NUGL/Kaya in a Transaction Valued at CAD $43,289,624.60; CSE to Halt Trading Until Shareholder Approval
Source: https://incomestatements.info
Category: Stock Reports